Laurus Labs Limited receives EIR from USFDA for API facilities

Laurus Labs Limited has received the Establishment Inspection Report (EIR), indicating closure of the inspection conducted by the United States Food & Drug Administration (USFDA) at our API manufacturing facilities Unit-1 and Unit-3, Parawada, Anakapalli (Visakhapatnam), Andhra Pradesh from 15th April, 2024 to 19th April, 2024.

Shares of Laurus Labs Limited was last trading in BSE at Rs. 424.25 as compared to the previous close of Rs. 423.75. The total number of shares traded during the day was 72341 in over 2876 trades.

The stock hit an intraday high of Rs. 430.95 and intraday low of 423.55. The net turnover during the day was Rs. 30811148.00.

Source : Equity Bulls

Keywords

LaurusLabs INE947Q01028 EIR USFDA Anakapalli AndhraPradesh APIManufacturingFacilities